{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:55:45Z","timestamp":1790834145255,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1038\/leu.2013.198","type":"journal-article","created":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T08:28:36Z","timestamp":1372667316000},"page":"321-328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Hyperdiploidy with 49\u201365 chromosomes represents a heterogeneous cytogenetic subgroup of acute myeloid leukemia with differential outcome"],"prefix":"10.1038","volume":"28","author":[{"given":"L","family":"Chilton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R K","family":"Hills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C J","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A K","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Grimwade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A V","family":"Moorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,1]]},"reference":[{"key":"BFleu2013198_CR1","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","volume":"116","author":"D Grimwade","year":"2010","unstructured":"Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, Goldstone AH et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 2010; 116: 354\u2013365.","journal-title":"Blood"},{"key":"BFleu2013198_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/gcc.20193","volume":"43","author":"C Schoch","year":"2005","unstructured":"Schoch C, Kern W, Kohlmann A, Hiddemann W, Schnittger S, Haferlach T . Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile. Genes Chromosomes Cancer 2005; 43: 227\u2013238.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu2013198_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","volume":"115","author":"H Dohner","year":"2010","unstructured":"Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010; 115: 453\u2013474.","journal-title":"Blood"},{"key":"BFleu2013198_CR4","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1200\/JCO.2012.43.4738","volume":"30","author":"K Mrozek","year":"2012","unstructured":"Mrozek K, Marcucci G, Nicolet D, Maharry KS, Becker H, Whitman SP et al. Prognostic significance of the European leukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia. J Clin Oncol 2012; 30: 4515\u20134523.","journal-title":"J Clin Oncol"},{"key":"BFleu2013198_CR5","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","volume":"92","author":"D Grimwade","year":"1998","unstructured":"Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children\u2019s Leukaemia Working Parties. Blood 1998; 92: 2322\u20132333.","journal-title":"Blood"},{"key":"BFleu2013198_CR6","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","volume":"100","author":"JC Byrd","year":"2002","unstructured":"Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002; 100: 4325\u20134336.","journal-title":"Blood"},{"key":"BFleu2013198_CR7","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1200\/JCO.2008.16.0259","volume":"26","author":"DA Breems","year":"2008","unstructured":"Breems DA, Van Putten WL, De Greef GE, Van Zelderen-Bhola SL, Gerssen-Schoorl KB, Mellink CH et al. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol 2008; 26: 4791\u20134797.","journal-title":"J Clin Oncol"},{"key":"BFleu2013198_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/leu.2010.258","volume":"25","author":"MM Patnaik","year":"2011","unstructured":"Patnaik MM, Hanson CA, Hodnefield JM, Knudson R, Van Dyke DL, Tefferi A . Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype. Leukemia Feb 2011; 25: 266\u2013270.","journal-title":"Leukemia Feb"},{"key":"BFleu2013198_CR9","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1182\/blood-2011-10-385781","volume":"119","author":"C Haferlach","year":"2012","unstructured":"Haferlach C, Alpermann T, Schnittger S, Kern W, Chromik J, Schmid C et al. Prognostic value of \"monosomal karyotype\" in comparison to \"complex aberrant karyotype\" in acute myeloid leukemia: study on 824 cases with aberrant karyotype. Blood 2012; 119: 2122\u20132125.","journal-title":"Blood"},{"key":"BFleu2013198_CR10","unstructured":"Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer (2013) In: Mitelman F, Johansson B and Mertens F (eds), http:\/\/cgap.nci.nih.gov\/Chromosomes\/Mitelman."},{"key":"BFleu2013198_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/sj.leu.2404974","volume":"22","author":"I Luquet","year":"2008","unstructured":"Luquet I, Lai JL, Barin C, Baranger L, Bilhou-Nabera C, Lippert E et al. Hyperdiploid karyotypes in acute myeloid leukemia define a novel entity: a study of 38 patients from the Groupe Francophone de Cytogenetique Hematologique (GFCH). Leukemia 2008; 22: 132\u2013137.","journal-title":"Leukemia"},{"key":"BFleu2013198_CR12","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1200\/JCO.2009.24.8997","volume":"28","author":"CJ Harrison","year":"2010","unstructured":"Harrison CJ, Hills RK, Moorman AV, Grimwade DJ, Hann I, Webb DK et al. Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12. J Clin Oncol 2010; 28: 2674\u20132681.","journal-title":"J Clin Oncol"},{"key":"BFleu2013198_CR13","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1182\/blood.V118.21.3529.3529","volume":"118","author":"J Damgaard Sandahl","year":"2011","unstructured":"Damgaard Sandahl J, Abrahamsson J, Heldrup J, Jahnukainen K, Jonsson OG, Lausen B et al. Hyperdiploidy in childhood AML associated with low age and AML-M7. A NOPHO-AML study and literature review [abstract]. Blood 2011; 118: 3529.","journal-title":"Blood"},{"key":"BFleu2013198_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/leu.2008.173","volume":"23","author":"D Bowen","year":"2009","unstructured":"Bowen D, Groves MJ, Burnett AK, Patel Y, Allen C, Green C et al. TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis. Leukemia 2009; 23: 203\u2013206.","journal-title":"Leukemia"},{"key":"BFleu2013198_CR15","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1182\/blood-2012-03-419622","volume":"120","author":"V Grossmann","year":"2012","unstructured":"Grossmann V, Schnittger S, Kohlmann A, Eder C, Roller A, Dicker F et al. A novel hierarchical prognostic model of AML solely based on molecular mutations. Blood 2012; 120: 2963\u20132972.","journal-title":"Blood"},{"key":"BFleu2013198_CR16","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1182\/blood-2011-08-375758","volume":"119","author":"FG Rucker","year":"2012","unstructured":"Rucker FG, Schlenk RF, Bullinger L, Kayser S, Teleanu V, Kett H et al. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome. Blood 2012; 119: 2114\u20132121.","journal-title":"Blood"},{"key":"BFleu2013198_CR17","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1200\/JCO.2009.25.6321","volume":"28","author":"C von Neuhoff","year":"2010","unstructured":"von Neuhoff C, Reinhardt D, Sander A, Zimmermann M, Bradtke J, Betts DR et al. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98. J Clin Oncol 2010; 28: 2682\u20132689.","journal-title":"J Clin Oncol"},{"key":"BFleu2013198_CR18","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1182\/blood-2007-02-072595","volume":"110","author":"F Dicker","year":"2007","unstructured":"Dicker F, Haferlach C, Kern W, Haferlach T, Schnittger S . Trisomy 13 is strongly associated with AML1\/RUNX1 mutations and increased FLT3 expression in acute myeloid leukemia. Blood 2007; 110: 1308\u20131316.","journal-title":"Blood"},{"key":"BFleu2013198_CR19","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/gcc.20380","volume":"45","author":"C Schoch","year":"2006","unstructured":"Schoch C, Kohlmann A, Dugas M, Kern W, Schnittger S, Haferlach T . Impact of trisomy 8 on expression of genes located on chromosome 8 in different AML subgroups. Genes, chromosomes & cancer 2006; 45: 1164\u20131168.","journal-title":"Genes, chromosomes & cancer"},{"key":"BFleu2013198_CR20","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/gcc.20671","volume":"48","author":"K Paulsson","year":"2009","unstructured":"Paulsson K, Johansson B . High hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 2009; 48: 637\u2013660.","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2013198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2013198","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2013198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:16:13Z","timestamp":1648739773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2013198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,1]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["BFleu2013198"],"URL":"https:\/\/doi.org\/10.1038\/leu.2013.198","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,1]]},"assertion":[{"value":"11 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}